Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Advertising News.
Press releases published on April 18, 2025
Exhale Wellness Review 2025: Is This CBD and Delta 9 THC Brand Worth It?
GlobeNewswire
·
April 18, 2025
North Carolina , April 18, 2025 (GLOBE NEWSWIRE) -- In the exhaustion of an everyday routine, we do not realize how we become more and more stressed. Thoughts start piling up and often we don’t get the sleep we require to wake up feeling refreshed. Further …
Best Berberine Supplement Ranked: Science Natural Supplements Berberine Fat Burner
GlobeNewswire
·
April 18, 2025
New York City, April 18, 2025 (GLOBE NEWSWIRE) -- Understanding the Metabolic Health Crisis in 2025 In today’s fast-paced world, millions silently suffer from the daily frustrations of poor metabolic health. Fatigue creeps in before noon. Weight clings on …
Studio Urbis Design in Lafayette Selected for 2025 East Bay Home Tours
EIN Presswire
·
April 18, 2025
Designed for life in sync with nature, the home balances privacy, openness, and topography in a wooded Lafayette setting. LAFAYETTE, CA, UNITED STATES, April 17, 2025 /EINPresswire.com/ -- Reciprocity House, designed by Studio Urbis, has been selected …
ESET Recognized as Finalist in SC Awards for Cutting-Edge Ransomware Remediation
EIN Presswire
·
April 18, 2025
DUBAI , DUBAI, UNITED ARAB EMIRATES, April 18, 2025 /EINPresswire.com/ -- ESET, a global leader in cybersecurity, today announced that it has been named a finalist in the prestigious 2025 SC Awards. ESET Ransomware Remediation has been recognized in the …
Scott+Scott Attorneys at Law LLP Reminds Investors that It is Investigating Ibotta, Inc. (NYSE: IBTA)
GlobeNewswire
·
April 18, 2025
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA) or certain of its officers and …
Long-Time Board Member Frances P. Philip Announces She Will Not Be Standing for Re-Election at 2025 Shareholder Meeting
GlobeNewswire
·
April 18, 2025
FORT WAYNE, Ind., April 18, 2025 (GLOBE NEWSWIRE) -- Vera Bradley (NASDAQ: VRA) (the “Company”) today announced that long-time board member Frances P. Philip will not stand for re-election at the upcoming 2025 Shareholder Meeting. Ms. Philip joined the …
Deadline Alert: Solaris Energy Infrastructure, Inc. (SEI) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
GlobeNewswire
·
April 18, 2025
LOS ANGELES, April 18, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay …
Pharmacy Benefit Management Institute® announces inaugural PBMI Innovators award to recognize leaders in pharmacy benefit management
GlobeNewswire
·
April 18, 2025
CRANBURY, NJ, April 18, 2025 (GLOBE NEWSWIRE) -- The Pharmacy Benefit Management Institute® (PBMI) is pleased to announce the launch of the PBMI Innovators awards, a new recognition program aimed at honoring outstanding professionals in pharmacy benefit …
DEADLINE NEXT WEEK: Berger Montague Advises Semtech Corporation (NASDAQ: SMTC) Investors to Contact the Firm Before April 22, 2025
GlobeNewswire
·
April 18, 2025
PHILADELPHIA, April 18, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Semtech Corporation (“Semtech” or the “Company”) (NASDAQ: SMTC) on behalf of purchasers of Semtech …
ROSEN, LEADING INVESTOR COUNSEL, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN
GlobeNewswire
·
April 18, 2025
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Geron Corporation (NASDAQ: GERN) between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class …
Verizon to report earnings April 22, 2025
GlobeNewswire
·
April 18, 2025
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report first-quarter 2025 earnings on Tuesday, April 22. The company will present results on a webcast beginning at 8:30 a.m. Eastern Time. First-quarter 2025 …
PRIME BIOME GUMMIES Latest Study 2025, Read Before Buying
GlobeNewswire
·
April 18, 2025
ST. PETERSBURG, Fla., April 18, 2025 (GLOBE NEWSWIRE) -- For the purpose of promoting gut health and overall wellness, a dietary supplement known as Prime Biome was developed. The microbiota in the gut, which is very important for immune response, …
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
GlobeNewswire
·
April 18, 2025
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite …
Steroids for Sale - Buy Steroids Online Where to Buy Legal Steroids for Sale form crazy bulk
GlobeNewswire
·
April 18, 2025
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Steroids for Sale, Where to Buy Steroids in USA, buy Steroids Online or Steroids for sale in USA are the top most searches of bodybuilders and Athletes in USA for muscle growth and lean muscle mass. Top Steroids …
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
GlobeNewswire
·
April 18, 2025
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo In the US, there are more …
Communiqué de presse : Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée
GlobeNewswire
·
April 18, 2025
Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée Aux États-Unis, le Dupixent est indiqué à plus de 300 000 adultes et adolescents âgés de 12 ans et …
Matsato Knife Reviews: Don’t Buy Until You Have Read This In-depth Guide
GlobeNewswire
·
April 18, 2025
KEARNY, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- For years, both home cooks and professional chefs have tussled with blunt, heavy, or fragile kitchen knives that either fail under pressure or make cooking a hassle. Sylvia Mendel, a culinary instructor …
JointRestore Gummies Under Review: Prosper Wellness CBD Gummies to Restore Joint Health
GlobeNewswire
·
April 18, 2025
New York City, April 18, 2025 (GLOBE NEWSWIRE) -- The Hidden Cost of Joint Pain Living with Joint Pain Isn't Just Physical—It's Emotional Joint pain isn't just an inconvenience—it's a silent thief that steals mobility, independence, and quality of life. …
Gluco Cleanse Tea Under Review: Healthy Blood Sugar Support Tea for Type 2 Diabetes
GlobeNewswire
·
April 18, 2025
New York City, April 18, 2025 (GLOBE NEWSWIRE) -- Introduction: Understanding the Diabetes Epidemic Type 2 diabetes has become one of the most pressing public health concerns of the 21st century. With over 400 million people affected globally, the …
Perpetua Resources Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit
GlobeNewswire
·
April 18, 2025
SAN DIEGO, April 18, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Perpetua Resources Corp. (NASDAQ: PPTA). The lawsuit seeks to recover losses on behalf of investors who …